NeuroSense Therapeutics (NRSN) Accounts Payables (2020 - 2026)
NeuroSense Therapeutics' Accounts Payables came in at $729,000 for Q2 2026, down 33.3% from $1.09 million a year earlier.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Accounts Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, NeuroSense Therapeutics' Accounts Payables was $799,000, down 31.1% from FY2024.
- Accounts Payables carries a five-year compound annual growth rate of 70.8% (FY2020 to FY2025).
- Going back by year, Accounts Payables was $1.16 million in FY2024 (-20.5%), $1.46 million in FY2023 (+193.0%), $498,000 in FY2022 and $39,000 in FY2021 (-29.1%).
- The Q2 2026 figure represents the lowest quarterly Accounts Payables since Q1 2023.
- Year-over-year, Accounts Payables increased in 1 of the last five quarters, with an average decline of 11.8%.
- The fastest year-over-year change in Accounts Payables over five years came in Q2 2023 (growth of 808.3%), and the weakest in Q2 2026 (a decline of 33.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.58 Bn |
| 10 | NeuroSense Therapeutics | 3.19 Mn | -1.26 Mn | - | 729,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 729,000.00 |
| Dec 31, 2025 | 799,000.00 |
| Jun 30, 2025 | 1.09 Mn |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | 1.39 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 2.38 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Sep 30, 2023 | 913,000.00 |
| Jun 30, 2023 | 1.09 Mn |
| Mar 31, 2023 | 419,000.00 |
| Dec 31, 2022 | 498,000.00 |
| Sep 30, 2022 | 206,000.00 |
| Jun 30, 2022 | 120,000.00 |
| Mar 31, 2022 | 180,000.00 |
| Dec 31, 2021 | 65,000.00 |
| Dec 31, 2020 | 55,000.00 |
API Access
NeuroSense Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();